IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2491 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Phase zero trials: a novel approach in drug development process
Neeraj Kumar Fuloria,Shivkanya Fuloria,Syed Vakiloddin
Renal Failure.2013;35(7)1044
[DOI]
2Optical imaging probes in oncology
Cristina Martelli,Alessia Lo Dico,Cecilia Diceglie,Giovanni Lucignani,Luisa Ottobrini
Oncotarget.2016;7(30)48753
[DOI]
3A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research
Dorian M. Cheff,Matthew D. Hall
Journal of Medicinal Chemistry.2017;60(11)4517
[DOI]
4Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist
Nader Sanai
Neurosurgery.2019;85(6)E967
[DOI]
5Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist
Tal Burt,Robert D. Combes
Neurosurgery.2019;85(6)229
[DOI]
6Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist
Gunasakaran Sambandan,Adina Turcu-Stiolica
Neurosurgery.2019;85(6)323
[DOI]
7First-in-human dose: current status review for better future perspectives
Archana Mishra,Sudhir Chandra Sarangi,Kh Reeta
European Journal of Clinical Pharmacology.2020;85(6)323
[DOI]
8Can prospective systematic reviews of animal studies improve clinical translation?
Pandora Pound,Merel Ritskes-Hoitinga
Journal of Translational Medicine.2020;18(1)323
[DOI]
9Performing radiosynthesis in microvolumes to maximize molar activity of tracers for positron emission tomography
Maxim Sergeev,Mark Lazari,Federica Morgia,Jeffrey Collins,Muhammad Rashed Javed,Olga Sergeeva,Jason Jones,Michael E. Phelps,Jason T. Lee,Pei Yuin Keng,R. Michael van Dam
Communications Chemistry.2018;1(1)323
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow